Rezolute Inc.

Rezolute Inc. focuses on clinical research in hypoglycemia associated with congenital hyperinsulinism, with attention to stabilizing blood glucose in patients affected by excessive insulin secretion. Its studies address the management of recurrent low blood sugar and the need for improved glycemic control.

• Continuous glucose management
• Hypoglycemia reduction
• Glucose requirements

The research activity in this area is centered on improving day-to-day metabolic stability for individuals living with this rare endocrine disorder.